Paper17526729
Hypoxia-inducible factor linked to differential kidney cancer risk seen with type 2A and type 2B VHL mutations.
Li L and 8 others. Mol Cell Biol, 2007. Cited by 90 papers, by iCite.
Cite this record
ConductScience Library. Hypoxia-inducible factor linked to differential kidney cancer risk seen with type 2A and type 2B VHL mutations. Papers, record 17526729. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17526729
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Basic Helix-Loop-Helix Proteins | Major topic |
| Carcinoma, Renal Cell | Major topic |
| Kidney Neoplasms | Major topic |
| Mutation | Major topic |
| Von Hippel-Lindau Tumor Suppressor Protein | Major topic |
| Animals | |
| Cell Cycle | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Down-Regulation | |
| Gene Expression Profiling | |
| Humans | |
| Mice | |
| Mutant Proteins | |
| Risk Factors | |
| Spheroids, Cellular | |
| Endothelial PAS Domain-Containing Protein 1 |
Source PubMed
References78
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16261165 | Renal cell carcinoma risk in type 2 von Hippel-Lindau disease correlates with defects in pVHL stability and HIF-1alpha interactions. | Oncogene | 2006 | https://conductscience.org/library/papers/16261165 | PubMed |
| 2 | 10353251 | The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. | Nature | 1999 | https://conductscience.org/library/papers/10353251 | PubMed |
| 3 | 10579999 | The Rbx1 subunit of SCF and VHL E3 ubiquitin ligase activates Rub1 modification of cullins Cdc53 and Cul2. | Genes Dev | 1999 | https://conductscience.org/library/papers/10579999 | PubMed |
| 4 | 14985465 | Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL-/- tumors. | Mol Cancer Res | 2004 | https://conductscience.org/library/papers/14985465 | PubMed |
| 5 | 11171994 | Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. | Proc Natl Acad Sci U S A | 2001 | https://conductscience.org/library/papers/11171994 | PubMed |
| 6 | 9238051 | Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. | Proc Natl Acad Sci U S A | 1997 | https://conductscience.org/library/papers/9238051 | PubMed |
| 7 | 11292861 | Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. | Science | 2001 | https://conductscience.org/library/papers/11292861 | PubMed |
| 8 | 16585181 | Regulation of E-cadherin expression by VHL and hypoxia-inducible factor. | Cancer Res | 2006 | https://conductscience.org/library/papers/16585181 | PubMed |
| 9 | 12209156 | Molecular basis of the VHL hereditary cancer syndrome. | Nat Rev Cancer | 2002 | https://conductscience.org/library/papers/12209156 | PubMed |
| 10 | 16339096 | Renal-cell carcinoma. | N Engl J Med | 2005 | https://conductscience.org/library/papers/16339096 | PubMed |
| 11 | 10587522 | Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein. | J Clin Invest | 1999 | https://conductscience.org/library/papers/10587522 | PubMed |
| 12 | 16103922 | A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. | PLoS Genet | 2005 | https://conductscience.org/library/papers/16103922 | PubMed |
| 13 | 14506252 | The von Hippel Lindau/hypoxia-inducible factor (HIF) pathway regulates the transcription of the HIF-proline hydroxylase genes in response to low oxygen. | J Biol Chem | 2003 | https://conductscience.org/library/papers/14506252 | PubMed |
| 14 | 11598268 | A conserved family of prolyl-4-hydroxylases that modify HIF. | Science | 2001 | https://conductscience.org/library/papers/11598268 | PubMed |
| 15 | 16098468 | Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. | Cancer Cell | 2005 | https://conductscience.org/library/papers/16098468 | PubMed |
| 16 | 11154273 | VHL induces renal cell differentiation and growth arrest through integration of cell-cell and cell-extracellular matrix signaling. | Mol Cell Biol | 2001 | https://conductscience.org/library/papers/11154273 | PubMed |
| 17 | 11292862 | HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. | Science | 2001 | https://conductscience.org/library/papers/11292862 | PubMed |
| 18 | 10205047 | Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. | Science | 1999 | https://conductscience.org/library/papers/10205047 | PubMed |
| 19 | 12124175 | HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron. | Cancer Cell | 2002 | https://conductscience.org/library/papers/12124175 | PubMed |
| 20 | 12086861 | The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma. | Cancer Cell | 2002 | https://conductscience.org/library/papers/12086861 | PubMed |
Cited by70
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 90 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40522994 | PHD3-VHL axis controls HIV-2 infection through oxygen-dependent hydroxylation and degradation of Vpx. | PLoS Pathog | 2025 | https://conductscience.org/library/papers/40522994 | PubMed |
| 39592433 | Loss of SETD2 in wild-type VHL clear cell renal cell carcinoma sensitizes cells to STF-62247 and leads to DNA damage, cell cycle arrest, and cell death characteristic of pyroptosis. | Mol Oncol | 2025 | https://conductscience.org/library/papers/39592433 | PubMed |
| 39281922 | Molecular Dynamics Reveals Altered Interactions between Belzutifan and HIF-2 with Natural Variant G323E or Proximal Phosphorylation at T324. | ACS Omega | 2024 | https://conductscience.org/library/papers/39281922 | PubMed |
| 37139155 | Deregulated expression of the 14q32 miRNA cluster in clear cell renal cancer cells. | Front Oncol | 2023 | https://conductscience.org/library/papers/37139155 | PubMed |
| 36358771 | The Clinical and Molecular Features in the VHL Renal Cancers; Close or Distant Relatives with Sporadic Clear Cell Renal Cell Carcinoma? | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36358771 | PubMed |
| 36106637 | Von Hippel-Lindau disease: insights into oxygen sensing, protein degradation, and cancer. | J Clin Invest | 2022 | https://conductscience.org/library/papers/36106637 | PubMed |
| 36040300 | Hypoxia-inducible factor underlies von Hippel-Lindau disease stigmata. | Elife | 2022 | https://conductscience.org/library/papers/36040300 | PubMed |
| 35740352 | p53 and Its Isoforms in Renal Cell Carcinoma-Do They Matter? | Biomedicines | 2022 | https://conductscience.org/library/papers/35740352 | PubMed |
| 35205407 | The Role of VHL in the Development of von Hippel-Lindau Disease and Erythrocytosis. | Genes (Basel) | 2022 | https://conductscience.org/library/papers/35205407 | PubMed |
| 35159281 | Multi-Omics Profiling to Assess Signaling Changes upon VHL Restoration and Identify Putative VHL Substrates in Clear Cell Renal Cell Carcinoma Cell Lines. | Cells | 2022 | https://conductscience.org/library/papers/35159281 | PubMed |
| 35158796 | The Obscure Potential of AHNAK2. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35158796 | PubMed |
| 34860252 | pVHL-mediated SMAD3 degradation suppresses TGF-β signaling. | J Cell Biol | 2022 | https://conductscience.org/library/papers/34860252 | PubMed |
| 33945366 | MK-6482 as a potential treatment for von Hippel-Lindau disease-associated clear cell renal cell carcinoma. | Expert Opin Investig Drugs | 2021 | https://conductscience.org/library/papers/33945366 | PubMed |
| 33020645 | Targeting the HIF2-VEGF axis in renal cell carcinoma. | Nat Med | 2020 | https://conductscience.org/library/papers/33020645 | PubMed |
| 32725274 | Interaction with p53 explains a pro-proliferative function for VHL in cancer. | J Mol Med (Berl) | 2020 | https://conductscience.org/library/papers/32725274 | PubMed |
| 31810986 | TBK1 Is a Synthetic Lethal Target in Cancer with VHL Loss. | Cancer Discov | 2020 | https://conductscience.org/library/papers/31810986 | PubMed |
| 31444342 | Structural basis of Cullin 2 RING E3 ligase regulation by the COP9 signalosome. | Nat Commun | 2019 | https://conductscience.org/library/papers/31444342 | PubMed |
| 30105105 | Bilateral Pheochromocytomas in a Patient with Y175C Von Hippel-Lindau Mutation. | Case Rep Endocrinol | 2018 | https://conductscience.org/library/papers/30105105 | PubMed |
| 30104738 | Endogenous HIF2A reporter systems for high-throughput functional screening. | Sci Rep | 2018 | https://conductscience.org/library/papers/30104738 | PubMed |
| 30026228 | VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma. | Science | 2018 | https://conductscience.org/library/papers/30026228 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| EPAS1 | 2034 | PubTator's text mining | https://conductscience.org/library/genes/2034 | NCBI Gene |
| VHL | 7428 | PubTator's text mining | https://conductscience.org/library/genes/7428 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17526729
GET https://conductscience.org/api/papers/v1/17526729/references?page=2